Thorne Healthtech, Inc.
THRNDelisted Oct 16, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001844280
Thorne Healthtech, Inc. was delisted on Oct 16, 2023; its insiders filed their last Form 4 on Oct 18, 2023; 59 institutions reported holding it in 13F filings for Q3 2023, worth $82.9M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Thorne Healthtech, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 44 | 45 | +1 |
| Shares | 5.54M | 4.78M | −763.5K (−13.8%) |
| Value | $26.2M | $17.4M | −$8.87M (−33.8%) |
New holders (7)
Institutions that held Thorne Healthtech, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| MYDA Advisors LLC | 150,000 | $544.5K | 0.39% |
| Millennium Management LLC | 30,068 | $109.0K | 0.00% |
| Dimensional Fund Advisors LP | 22,546 | $82.0K | 0.00% |
| Citadel Advisors LLC | 16,236 | $58.9K | 0.00% |
| Invesco Ltd. | 12,981 | $47.1K | 0.00% |
| Virtu Financial LLC | 12,457 | $45.0K | 0.01% |
| UBS Group AG | 2,148 | $7.80K | 0.00% |
Sold out (6)
Institutions that held Thorne Healthtech, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Driehaus Capital Management LLC | 1,020,098 | $4.83M |
| Martingale Asset Management L P | 16,024 | $76.0K |
| Susquehanna International Group, LLP | 10,646 | $50.0K |
| BNP Paribas Arbitrage, SA | 2,905 | $13.7K |
| Wells Fargo & Company | 242 | $1.00K |
| Glassman Wealth Services | 83 | $0 |